Altamira Therapeutics LtdNASDAQ:CYTONASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.4146
- TODAY'S CHANGE (%)-0.0454 (-9.8696%)
- Bid / Lots0.4072/ 10
- Ask / Lots0.4187/ 1
- Open / Previous Close0.4510 / 0.4600
- Day Range
- 52 Week Range
- Volume110,906
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CYTO |
|---|---|---|
| 09:32 ET | 467 | 0.451 |
| 09:55 ET | 500 | 0.4735 |
| 10:06 ET | 215 | 0.4501 |
| 10:09 ET | 200 | 0.45 |
| 10:11 ET | 500 | 0.4726 |
| 10:20 ET | 300 | 0.492245 |
| 10:22 ET | 111 | 0.4922 |
| 10:26 ET | 2162 | 0.4761 |
| 10:31 ET | 260 | 0.4761 |
| 10:33 ET | 100 | 0.4761 |
| 10:36 ET | 200 | 0.4761 |
| 10:42 ET | 100 | 0.451 |
| 10:54 ET | 269 | 0.48 |
| 10:56 ET | 905 | 0.47 |
| 11:03 ET | 1625 | 0.46545 |
| 11:14 ET | 200 | 0.4655 |
| 11:36 ET | 2842 | 0.451 |
| 11:57 ET | 100 | 0.4656 |
| 12:08 ET | 2200 | 0.455 |
| 12:10 ET | 362 | 0.455 |
| 12:24 ET | 7663 | 0.45 |
| 12:33 ET | 500 | 0.4496 |
| 12:37 ET | 3240 | 0.4322 |
| 12:48 ET | 100 | 0.4594 |
| 12:55 ET | 2500 | 0.435 |
| 12:57 ET | 730 | 0.4403 |
| 01:00 ET | 6301 | 0.433 |
| 01:09 ET | 300 | 0.4322 |
| 01:31 ET | 2635 | 0.4322 |
| 01:33 ET | 2471 | 0.43 |
| 01:36 ET | 5322 | 0.4278 |
| 01:38 ET | 925 | 0.4202 |
| 01:40 ET | 2383 | 0.412 |
| 01:44 ET | 2500 | 0.412 |
| 01:45 ET | 500 | 0.4289 |
| 01:58 ET | 6217 | 0.4111 |
| 02:00 ET | 700 | 0.4069 |
| 02:02 ET | 892 | 0.4 |
| 02:03 ET | 1259 | 0.4145 |
| 02:16 ET | 3571 | 0.42 |
| 02:23 ET | 4500 | 0.4145 |
| 02:30 ET | 100 | 0.438 |
| 02:32 ET | 10000 | 0.4352 |
| 02:36 ET | 500 | 0.426249 |
| 02:41 ET | 225 | 0.438 |
| 02:56 ET | 2804 | 0.438 |
| 03:06 ET | 100 | 0.428394 |
| 03:10 ET | 1893 | 0.42 |
| 03:12 ET | 6700 | 0.42 |
| 03:14 ET | 100 | 0.42 |
| 03:26 ET | 100 | 0.42 |
| 03:35 ET | 1500 | 0.42 |
| 03:37 ET | 906 | 0.42 |
| 03:42 ET | 2501 | 0.419945 |
| 03:51 ET | 100 | 0.41451 |
| 04:00 ET | 406 | 0.4146 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Altamira Therapeutics Ltd | 1.7M | 0.6x | --- |
60 Degrees Pharmaceuticals Inc | 1.9M | 1.0x | --- |
Nexien Biopharma Inc | 1.4M | -5.5x | --- |
Cann American Corp | 1.2M | 0.0x | --- |
Psyence Biomedical Ltd | 2.8M | -1.3x | --- |
SymBio Pharmaceuticals Ltd | 71.7M | -2.0x | --- |
Company Information
Altamira Therapeutics Ltd. is a Bermuda-based company engaged in developing ribonucleic acid (RNA)-based therapeutics for extrahepatic targets (OligoPhore/SemaPhore delivery platforms). The Company has two flagship short interfering (siRNA) programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis. The delivery platform is also suited for messenger RNA (mRNA) and other types of RNA therapeutics and is focused to be leveraged via out-licensing to pharma or biotech companies. The therapeutic objective for AM-401 is to slow down KRAS driven tumor cell proliferation or to stop it altogether by delivering siRNA specifically inside tumor cells for gene knock down. AM-411 is a polyplex nanoparticle delivering siRNA to inflamed tissues to target the NF-kB signaling pathway, a critical regulator of immune and inflammatory responses. Like AM-401, the drug product is based on its OligoPhore technology.
Contact Information
- Headquarters
- Clarendon House, 2 Church StreetHAMILTON, ZUG, Bermuda 6300
- Phone
- ---
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.7M |
|---|---|
Revenue (TTM) | $59.6K |
Shares Outstanding | 3.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.44 |
EPS | $0.68 |
Book Value | $-0.08 |
P/E Ratio | 0.6x |
Price/Sales (TTM) | 29.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,159.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
